Personal profile
About
Dr. Alison Conlin is a physician and researcher at the Providence Cancer Institute in Portland, Oregon. She is a medical oncologist who leads the breast cancer program in medical oncology for the institute. She specializes in the treatment of breast cancer and other high risk breast conditions and completed her fellowship training at Memorial Sloan-Kettering Cancer Center in 2008. She also has a Master’s degree in Public Health Degree from Boston University where she focused on health services research.
Dr. Conlin has an interest in clinical trials and getting those to patients for all stages of breast cancer. Specifically she has written clinical trials for patients with advanced breast cancer and with brain metastases from breast cancer. Additionally she worked with the American Cancer Society focusing on cancer screening, prevention and follow-up care in the Oregon Health Study. She is passionate about the care of patients and getting the best resources to them.
She lives in Portland with her 3 children and husband.
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site
Drescher, C. (PI), Alluri, K. (CoPI), Conlin, A. (CoPI), Bridges, B. (CoPI), Zuckerman, D. S. (CoPI), Murray, D. D. (CoPI), Goodman, G. (CoPI), Gallaher, I. I. (CoPI), Lanier, K. S. (CoPI), Montgomery, P. (CoPI), Alluri, N. N. (CoPI) & Ramsey, S. D. (CoPI)
08/1/14 → 07/31/26
Project: Research
-
WESTERN ONCOLOGY RESEARCH CONSORTIUM
Doty, G. L. (CoPI), Conlin, A. (PI), Lanier, K. S. (CoPI) & Ruzich, J. (CoPI)
08/28/87 → 07/31/14
Project: Research
-
Exploring decisional control preferences in older patients with cancer and their caregivers
Hryniv, S., Gilbride, E., Consagra, W., Mohile, S., Yilmaz, S., Kyi, K., Kadambi, S., Jensen-Battaglia, M., Gilmore, N., Whitehead, M., Khatri, J., Braiteh, F. S., Conlin, A., Loh, K. P. & Magnuson, A., Mar 2026, In: Journal of Geriatric Oncology. 17, 2, 102832.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Longitudinal multi-omic profiling of tissues and blood to track the molecular evolution of metastatic breast cancer
Kaplan, H. G., Dowdell, A. K., Wagner, J. T., Reynolds, S., Carney, C. A., Rosemon, J., Page, D. B., Conlin, A., McCormick, K., Yan, F., Johnston, E., File, D., Wahl, T., Lopez, J., Topp, Z., Paulson, K. G., Xie, B., Montgomery, S., Schnettler, E. & Sathyan, P. & 3 others, , Feb 17 2026Research output: Other contribution
-
Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancer
Su, A., Hong, E. C., Moxon, N., Mellinger, S. L., Kelly, T., Conlin, A. K., Topp, Z. Z., Newell, P., Fredrich, N., Massimino, K. P., Wu, Y., Martel, M., Redmond, W. L., Aliabadi-Wahle, S., Sun, Z., Imatani, J., Stanton, S. E., Hanes, D. A., Simanonok, M. & Rosales, W. & 2 others, , Dec 2026, In: npj Breast Cancer. 12, 1, 66.Research output: Contribution to journal › Article › peer-review
Open Access -
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02☆
HER2CLIMB-02 study investigators, Mar 2026, In: Annals of Oncology. 37, 3, p. 341-352 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study
Tolaney, S. M., Jhaveri, K., Helsten, T., Puhalla, S. L., Conlin, A., Dees, E. C., Beeram, M., Chapman, S. C., Lithio, A., Litchfield, L. M. & Goetz, M. P., 2025, In: Frontiers in Oncology. 15, 1555921.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations